Drugs Made In America Acquisition Corp. · NASDAQ:DMAA
First Trust Capital Management L.P. reported a 6.17% stake in Drugs Made In America Acquisition Corp. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
First Trust Capital Management L.P. reported a 6.17% stake in Drugs Made In America Acquisition Corp., 2,066,702 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 6.17%
- Shares
- 2,066,702
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| First Trust Merger Arbitrage Fund | 5.32% | 1,781,724 |
| First Trust Capital Management L.P. | 6.17% | 2,066,702 |
| First Trust Capital Solutions L.P. | 6.17% | 2,066,702 |
| FTCS Sub GP LLC | 6.17% | 2,066,702 |
Source
Related
- Drugs Made In America Acquisition Corp.
- First Trust Capital Management L.P.
- Drugs Made In America Acquisition Corp. shareholders
- Schedule 13G/A · First Trust Capital Management L.P. · Aug 14, 2026
- Schedule 13G/A · Karpus Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Glazer Capital, LLC · Aug 13, 2026
- Schedule 13G/A · Mizuho Financial Group Inc · Aug 13, 2026
- Schedule 13G · Feis Equities LLC · Jun 26, 2026
- Schedule 13G · Mizuho Financial Group Inc · May 14, 2026